Abstract
Psoriasis and its related manifestations, including psoriatic arthritis, are prevalent disorders in the Western world, particularly among Caucasians. The study of these disorders in Latin America lags way behind the study of other more common rheumatic disorders, such as rheumatoid arthritis and systemic lupus erythematosus. From the scarce evidence available, however, it appears that the prevalence and incidence of psoriasis and psoriatic arthritis are lower than in other parts of the Western world and almost negligible among natives from the Andean region, although confirmatory epidemiologic studies are lacking.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
• Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009; 361:496–509. This is a carefully written review on the molecular mechanisms as well as the clinical autoimmune nature of psoriasis
Gladman DD. Mortality in psoriatic arthritis. Clin Exp Rheumatol. 2008;26(5 Suppl 51):S62–5.
•• McGonagle D, Benjamin M, Tan AL. The pathogenesis of psoriatic arthritis and associated nail disease: not autoimmune after all? Curr Opin Rheumatol. 2009; 21:340–7. This is a review of microanatomic and genetic studies of PsA, psoriasis, and psoriatic-associated nail disease showing that current autoimmunity concepts for psoriatic disease need to be re-examined as they pertain to joint and nail disease to understand the psoriatic disease spectrum.
• Chandran V, Raychaudhuri SP. Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. J Autoimmun. 2010;34:314–21. This is a carefully written review on the epidemiology and genetics of psoriasis and PsA.
• Gladman DD. Spondyloarthropathies: targeted therapy for psoriatic arthritis. Nat Rev Rheumatol. 2009;5:241–2. This is a review describing TNF inhibitors as effective therapeutic options in PsA, as well as novel therapies targeting other cytokines.
Belizán JM, Cafferata ML, Belizán M, et al. Health inequality in Latin America. Lancet. 2007;370:1599–600.
•• Nabel EG, Stevens S, Smith R. Combating chronic disease in developing countries. Lancet. 2009; 373:2004–6. This is a carefully written paper on the effects of globalization on health outcomes and how the global health landscape is changing from infectious diseases to the presence of chronic diseases, which are witnessing an increased frequency of deaths occurring in low- and middle-income countries.
Tugwell P, Sitthi-Amorn C, Hatcher-Roberts J, et al. Health Research Profile to assess the capacity of low and middle income countries for equity-oriented research. BMC Public Health. 2006;12(6):151.
Arriaza BT. Seronegative spondyloarthropathies and diffuse idiopathic skeletal hyperostosis in ancient northern Chile. Am J Phys Anthropol. 1993;91:263–78.
White C, Maxwell J, Dolphin A, et al. Pathoecology and paleodiet in postclassic/historic Maya from Northern Coastal Belize. Mem Inst Oswaldo Cruz. 2006;101 Suppl 2:35–42.
Aceves-Avila FJ, Báez-Molgado S, Medina F, et al. Paleopathology in osseous remains from the 16th century. A survey of rheumatic diseases. J Rheumatol. 1998;25:776–82.
Gerszten PC, Gerszten E, Allison M. Diseases of the spine in South American mummies. Neurosurgery. 2001;48:208–13.
Verlaan JJ, Oner FC, Maat GJ. Diffuse idiopathic skeletal hyperostosis in ancient clergymen. Eur Spine J. 2007;16:1129–35.
Castillo-Ojugas A. Description of psoriatic arthropathy in the 17th century. Arthritis Rheum. 1991;32:812–3.
• Iglesias Gammarra A, Penaranda E, Hernando P, et al. History of psoriatic arthritis. First part. From Alibert to V. Wright. Rev.Colomb.Reumatol. 2010; 17(1): 22–34. This is an historical overview of PsA with a description of the first case of PsA occurring in Latin America.
Zias J, Mitchell P. Psoriatic arthritis in a fifth-century Judean Desert monastery. Am J Phys Anthropol. 1996;101(4):491–502.
Peschken CA, Esdaile JM. Rheumatic diseases in North America’s indigenous peoples. Semin Arthritis Rheum. 1999;28(6):368–91.
Alamanos Y, Voulgari P, Drosos A. Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol. 2008;35:354–8.
Convit J. Investigation of the incidence of psoriasis amongst Latin-American Indians. In Proceedings of 13th Congress on Dermatology. Amsterdam: Excerpta Medica, 1962; 196.
IPC psoriasis review. Available at http://www.psoriasiscouncil.org/publications/newsletters. Accessed November 2010.
Machado APB, Ataíde D, Sandri C, et al. Importância do raio X e exame físico no diagnóstico da artrite psoriática e sua prevalência no Hospital Universitário Evangélico de Curitiba (HUEC). An Bras Dermatol. [online]. 2005; 80(suppl.3) [cited 2010-11-02], pp. S345–S351.
Consenso Latinoamericano de Psoriasis. Guias de Tratamiento. Available at http://www.solapso.org/archivos/LATINOAMERICANO-1_2010.pdf. Accessed November 2010.
Vázquez-Mellado J, Font Ugalde P, Muñoz Gomáriz E, et al. Eduardo Collantes Estévez Registro Iberoamericano de Espondiloartritis (RESPONDIA): ¿qué es, cómo surgió, quiénes somos y qué hacemos? Metodología general. Reumatol Clin. 2008;4:17–22.
Bellomio V, Berman A, Sueldo R, et al. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Argentina. Reumatol Clin. 2008;4:23–9.
Sampaio-Barros P, Gonçalves C, BragadaSilva J. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Brasil. Informe del Registro Brasileño de Espondiloartritis. Reumatol Clin. 2008;4:30–5.
Gutiérrez M, Pérez C, Saavedra J, et al. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Chile. Reumatol Clin. 2008;4:41–7.
Casasola-Vargas J, Flores-Alvarado D, Huerta-Sil G, et al. Registro Iberoamericano de Espondiloartritis (RESPONDIA): México. Reumatol Clin. 2008;4:56–62.
Chávez-Corrales J, Montero Jáuregui M, Alva Linares M, et al. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Perú. Reumatol Clin. 2008;4:63–7.
Palleiro D, Spangenberg E. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Uruguay. Reumatol Clin. 2008;4:73–8.
Chacón R, Granados Y, Esteva MH, et al. Registro Iberoamericano de Espondiloartritis (RESPONDIA): Venezuela. Reumatol Clin. 2008;4:79–86.
Rodriguez Gil G, Citera G, Granel A, Arturi A, Maldonado Cocco JA. Caracterización clínica e inmunogenética de pacientes con artritis psoriásica. Rev Arg Reumatol. 2002;13:26.
Bonfiglioli R, Conde RA, Sampaio-Barros PD, et al. Frequency of HLA-B27 alleles in Brazilian patients with psoriatic arthritis. Clin Rheumatol. 2008;27(6):709–12.
Trentin F, Felix J, Ekkehard G, et al. Psoriatic arthritis: clinical aspects and associations with HLA-B loci. Rev Bras Reumatol. 1999;39(5):263–8.
Acknowledgments
The authors wish to express their gratitude and appreciation to Prof. Vinod Chandran at the University of Toronto for his critical review of the manuscript and his insightful comments and suggestions. They also wish to thank Dr. Janitzia Vasquez-Mellado from Mexico for her collaboration with the RESPONDIA data.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Toloza, S.M.A., Valle-Oñate, R. & Espinoza, L.R. Psoriatic Arthritis in South and Central America. Curr Rheumatol Rep 13, 360–368 (2011). https://doi.org/10.1007/s11926-011-0185-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11926-011-0185-7